Advisors Capital Management LLC Increases Stock Position in CVS Health Corporation $CVS

Advisors Capital Management LLC raised its stake in shares of CVS Health Corporation (NYSE:CVS) by 9.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 249,798 shares of the pharmacy operator’s stock after purchasing an additional 21,589 shares during the period. Advisors Capital Management LLC’s holdings in CVS Health were worth $18,832,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently made changes to their positions in CVS. Norges Bank bought a new stake in CVS Health in the 2nd quarter worth approximately $1,358,698,000. Invesco Ltd. increased its position in CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after purchasing an additional 3,118,626 shares during the last quarter. Jennison Associates LLC raised its stake in CVS Health by 111.7% during the second quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator’s stock valued at $276,895,000 after purchasing an additional 2,117,798 shares in the last quarter. Vanguard Group Inc. lifted its position in CVS Health by 1.7% during the second quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after purchasing an additional 2,063,737 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its stake in shares of CVS Health by 153.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,105,827 shares of the pharmacy operator’s stock worth $214,240,000 after buying an additional 1,878,217 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Bank of America decreased their target price on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research report on Tuesday, January 27th. Mizuho upped their price objective on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, December 10th. Evercore lifted their target price on CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Argus lowered their price target on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Finally, Wolfe Research boosted their price objective on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, December 8th. Nineteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Stock Down 0.5%

NYSE:CVS opened at $78.12 on Wednesday. The company has a market cap of $99.39 billion, a price-to-earnings ratio of 56.61, a price-to-earnings-growth ratio of 0.82 and a beta of 0.50. CVS Health Corporation has a twelve month low of $58.35 and a twelve month high of $85.15. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The stock has a fifty day simple moving average of $78.67 and a 200-day simple moving average of $76.56.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. During the same period in the prior year, the business posted $1.19 earnings per share. The business’s revenue for the quarter was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is currently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.